Literature DB >> 14709199

Unique approach to derivation of random error in laboratory assays: application to glycohemoglobin testing demonstrates poor clinical performance for immunochemistry assay.

David V Tran1, Tammy L Hofer, Terrence Lee, George S Cembrowski.   

Abstract

The measurement of glycohemoglobin is the best measure of mean glucose within a 3-4 month range. As it is used for patient education, counseling, feedback control, and ultimately for patient motivation, its measurement should be optimally accurate and precise. Duplicate hemoglobin A1c readings were used to determine physiological (changes over time between measurements) and analytic variation of two widely used laboratory assays: Bio-Rad Variant II's high-performance liquid chromatography (HPLC) system and Roche's immunoassay. The average variation of grouped duplicates was calculated and graphed against corresponding time intervals. Regression to the y-intercept (0 day separation between readings) was used to determine the analytic variation. Analytic coefficients of variation (CVs) for the HPLC and immunoassay were determined as 2.6% and 5.1%, respectively. The CV of the immunoassay method exceeds physiologically established limits of 2-3% and those of the National Glycohemoglobin Standardization Program (3-4%). The Bio-Rad HPLC system produces a CV within these limits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14709199     DOI: 10.1089/152091503322641015

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  5 in total

1.  Use of serial patient hemoglobin A1c differences to determine long-term imprecision of immunoassay and high-performance liquid chromatography analyzers.

Authors:  David V Tran; Andrew W Lyon; Trefor N Higgins; James C Wesenberg; Lisa Vandergouwe; Carmen L Wiley; George S Cembrowski
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

2.  Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study.

Authors:  Kendra L Schwartz; Joseph C Monsur; Monina G Bartoces; Patricia A West; Anne Victoria Neale
Journal:  BMC Fam Pract       Date:  2005-07-13       Impact factor: 2.497

3.  Walking behaviour and glycemic control in type 2 diabetes: seasonal and gender differences--study design and methods.

Authors:  Kaberi Dasgupta; Cathy Chan; Deborah Da Costa; Louise Pilote; Mirella De Civita; Nancy Ross; Ian Strachan; Ronald Sigal; Lawrence Joseph
Journal:  Cardiovasc Diabetol       Date:  2007-01-15       Impact factor: 9.951

4.  Step Monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods.

Authors:  Kaberi Dasgupta; Ellen Rosenberg; Stella S Daskalopoulou
Journal:  Cardiovasc Diabetol       Date:  2014-01-06       Impact factor: 9.951

5.  Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross-sectional survey of 15,652 patients.

Authors:  Keiko Arai; Masahiko Takai; Koichi Hirao; Ikuro Matsuba; Kiyokazu Matoba; Hiroshi Takeda; Akira Kanamori; Mikio Yamauchi; Hisao Mori; Yasuo Terauchi
Journal:  J Diabetes Investig       Date:  2012-08-20       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.